InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000071 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28+ MET Goulart Steven J EVP, CIO F - Tax $71.68 -52.6K 327.9K -14% -$3.77M
DM 2023-03-02 2023-02-28 MET Goulart Steven J EVP, CIO A - Grant — +101.6K 282.9K +56% —
D 2023-03-02 2023-02-28 MET Goulart Steven J EVP, CIO A - Grant $0.00 +28.9K 28.9K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 F D 5,565 $71.27 322,300 D — —
2 Common Common Stock 2023-02-28 F D 47,045 $71.73 327,865 D — —
3 Common Common Stock 2023-02-28 A A 91,980 — 374,910 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Common Common Stock 2023-02-28 A A 9,620 — 282,930 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 28,859 $0.00 28,859 D $71.73 · — to 2033-02-27 28,859 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.